In 2011, Cannabidiol improves brain and liver function in a fulminant hepatic failure-induced model in mice.
BACKGROUND: Investigated the effects of cannabidiol, a non-psychoactive constituent of Cannabis sativawith anti-inflammatory properties that activates the 5-hydroxytryptamine receptor 5-HT1A, on brain and liver functions in a model of hepatic encephalopathy associated with fulminant hepatic failure induced in mice by thioacetamide.
You can read the full article here => https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3057300/
